Status:

COMPLETED

Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors

Lead Sponsor:

University of Nottingham

Collaborating Sponsors:

National Institute for Health Research, United Kingdom

International Stem Cell Forum

Conditions:

Quality of Life

Cancer

Eligibility:

All Genders

18+ years

Brief Summary

This project aims to explore, in depth, the burden of hearing loss and tinnitus on cancer survivors. Using semi-structured interviews, audiograms and a variety of validated questionnaires, the specifi...

Detailed Description

The medical and technological advances in cancer research have caused a decline in cancer deaths in recent decades. For example, the 5-year survival rate now is above 80% for many adult cancers, inclu...

Eligibility Criteria

Inclusion

  • Has had platinum-based chemotherapy between 0-5 years ago
  • Has had at least 1 cycle- Was an adult (over 18) at the time of cancer diagnosis

Exclusion

  • Pre-existing hearing issues
  • Radiotherapy to the head and neck area

Key Trial Info

Start Date :

September 5 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 28 2020

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04281953

Start Date

September 5 2019

End Date

February 28 2020

Last Update

March 25 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Nottingham

Nottingham, Nottinghamshire, United Kingdom, NG7 2RD

Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors | DecenTrialz